China Drugmaker Kintor Up 229% After Reporting Covid Pill Effect

Chinese drug maker Kintor Pharmaceutical Ltd. soared in Hong Kong after saying its pill was highly effective in reducing the risk of hospitalization or deaths related to Covid-19, raising the prospect of a first homegrown antiviral treatment. Shares were up 141% as of 11:06 a.m. local time after earlier surging as much as 229%, the biggest jump since the company’s Hong Kong listing in mid-2020. The stock was also the best performer on the the Hang Seng Composite Index, which slid 1.6%.